K. David Campagnari
Presidente presso Induce Biologics, Inc.
Posizioni attive di K. David Campagnari
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Induce Biologics, Inc.
 Induce Biologics, Inc. BiotechnologyHealth Technology Induce Biologics, Inc. is a medicine company. The firm is develops bio implants for bone regeneration. It also offers URIST product. The company was founded by Sean Peel and is headquartered in Toronto, Canada. | Direttore operativo | - | - |
| Presidente | - | - |
Storia della carriera di K. David Campagnari
Precedenti posizioni note di K. David Campagnari
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Direttore operativo | 01/06/2002 | 24/03/2010 |
Formazione di K. David Campagnari
| National University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Canada | 3 |
| Stati Uniti | 2 |
Posizioni
| Chief Operating Officer | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
Induce Biologics, Inc.
Induce Biologics, Inc. BiotechnologyHealth Technology Induce Biologics, Inc. is a medicine company. The firm is develops bio implants for bone regeneration. It also offers URIST product. The company was founded by Sean Peel and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- K. David Campagnari
- Esperienza
